GSK launches $2.5 billion buyback, lifts sales target after ... - MSN

By Yadarisa Shabong (Reuters) -GSK launched a 2 billion pounds ($2.5 billion) share buyback on Wednesday and lifted its long-term sales target to nearly $50 billion, betting that growing sales …

CouponFollow Extension

$2
OFF

GSK Launches $2.5 Billion Buyback, Lifts Sales Target After ... - MSN

2 weeks from now

By Yadarisa Shabong (Reuters) -GSK launched a 2 billion pounds ($2.5 billion) share buyback on Wednesday and lifted its long-term sales target to nearly $50 billion, betting that growing sales …

msn.com

$2
OFF

GSK Launches $2.5 Billion Buyback, Lifts Sales Target After Stellar ...

2 weeks from now

3 days ago · GSK launched a 2 billion pounds ($2.5 billion) share buyback on Wednesday and lifted its long-term sales target to nearly $50 billion, betting that growing sales of its HIV and …

reuters.com

£40
OFF

GSK Lifts Long-Term Outlook On Drug Pipeline, Buys Back Shares

2 weeks from now

The share buyback will be implemented over the next 18 months. “GSK needs more pipeline wins to narrow the gap between its 2031 sales target of £40 billion and consensus’ £34 billion ...

msn.com

$2
OFF

GSK Launches $2.5 Billion Buyback, Raises Midterm Sales Outlook

2 weeks from now

3 days ago · GSK GSK 6.38 % increase; green up pointing triangle plans to buy back $2.50 billion in shares and raised its midterm sales target, citing promising pipeline developments.

wsj.com

1%
OFF

GSK Q4 Earnings: Revenue And EPS Beat, Initiates $2.5 Billion …

2 weeks from now

3 days ago · Wednesday, GSK Plc (NYSE:GSK) reported fourth-quarter sales of $10.40 billion (8.12 billion Sterling Pounds), up 1% year-over-year and up 4% on constant currency. The …

yahoo.com

£2
OFF

GSK Launches £2bn Share Buyback And Upgrades Sales Forecast

2 weeks from now

3 days ago · Strong growth in HIV, oncology and specialty medicines have offset a 4 per cent decline in vaccine sales

thetimes.com

$2
OFF

GSK Launches $2.5 Bln Buyback, Lifts Sales Target After Stellar Q4

2 weeks from now

GSK launched a 2 billion pounds ($2.5 billion) share buyback on Wednesday and lifted its long-term sales target to nearly $50 billion, betting that growing sales of its HIV and cancer drugs …

msn.com

$2
OFF

GSK Issues $2.5 Billion Buyback, Raises Midterm Outlook After …

2 weeks from now

3 days ago · The British pharmaceutical giant said Wednesday that the 2.0 billion-pound share buyback will be implemented over the next 18 months. The company said it now expects sales …

marketscreener.com

$2
OFF

GSK Launches $2.5 Billion Buyback, Raises Midterm Sales Outlook

2 weeks from now

3 days ago · GSK plans to buy back $2.50 billion in shares and raised its midterm sales target, citing promising pipeline developments. The British pharmaceutical company said Wednesday …

marketscreener.com

$25
OFF

GlaxoSmithKline Unveils $25 Billion Buyback - MarketWatch

2 weeks from now

LONDON (MarketWatch) -- GlaxoSmithKline on Wednesday took some of the attention away from disappointing sales of diabetes drugs by lifting its stock-buyback authorization to 12 billion …

marketwatch.com

14%
OFF

GSK Q4 Earnings: Revenue And EPS Beat, Initiates $2.5 Billion …

2 weeks from now

3 days ago · The company announced a $2.5 billion share buyback plan. GSK's Q4 sales hit $10.40 billion, topping estimates. Specialty Medicines grew 14%, while vaccines declined. The …

benzinga.com

5%
OFF

FTSE 100 Live 05 February: GSK Shares Surge On New Guidance, …

2 weeks from now

The blue-chip rallied 5% or 76.5p to 1456.5p as investors also cheered plans for an increased 2025 dividend and a £2 billion buyback of shares. GSK is now targeting 2031 sales of more …

msn.com

$2
OFF

GSK Issues $2.5 Billion Buyback, Raises Midterm Outlook After …

2 weeks from now

3 days ago · By Helena Smolak GSK plans to buy back $2.50 billion in shares and raised its midterm sales target, citing promising pipeline developments. The British pharmaceutical giant …

marketscreener.com

$250
OFF

Gun Buyback NJ Results In Largest Single-day Surrender - Bergen …

2 weeks from now

Oct 28, 2021 · The program offered $250 for each assault weapon, $200 per handgun, $125 per rifle, $25 for inoperable firearms and pellet guns, with no questions asked, officials said.

northjersey.com

FAQs about GSK launches $2.5 billion buyback, lifts sales target after ... - MSN Coupon?

Will GSK increase its sales to $50 billion?

For more news like this visit The Economic Times. GSK launched a 2 billion pounds ($2.5 billion) share buyback on Wednesday and lifted its long-term sales target to nearly $50 billion, betting that growing sales of its HIV and cancer drugs will make up for pressures on its vaccines revenue. ...

Will GSK buy back £2 billion?

(Bloomberg) -- GSK Plc plans to buy back £2 billion ($2.5 billion) of shares as it raised its long-term growth outlook on optimism around the drug pipeline. The British drugmaker boosted its 2031 sales forecast to over £40 billion, up from the more than £38 billion it previously expected. ...

When will GSK's share buyback be implemented?

The share buyback will be implemented over the next 18 months. “GSK needs more pipeline wins to narrow the gap between its 2031 sales target of £40 billion and consensus’ £34 billion,” Bloomberg Intelligence’s senior industry analyst John Murphy said in a note. ...

What was GSK's fourth-quarter sales?

Wednesday, GSK Plc (NYSE: GSK) reported fourth-quarter sales of $10.40 billion (8.12 billion Sterling Pounds), up 1% year-over-year and up 4% on constant currency. The analysts estimated sales of $9.58 billion. ...

Why did GSK boost its 2031 sales forecast?

The British drugmaker boosted its 2031 sales forecast to over £40 billion, up from the more than £38 billion it previously expected. GSK said this reflected progress in late stage drug development, including several oncology medicines. ...

How did GSK perform in Q4 2024?

GSK’s sales for the fourth quarter of 2024 rose 4% at constant currencies to 8.12 billion pounds, above the 7.83 billion pounds that analysts had expected, according to a consensus poll by Visible Alpha. ...